First Time Loading...

Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 3.67 USD
Updated: Mar 28, 2024

Chromadex Corp
Net Income (Common)

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Chromadex Corp
Net Income (Common) Peer Comparison

Comparables:
TMO
DHR
WST
A
IQV

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Chromadex Corp
NASDAQ:CDXC
Net Income (Common)
$-4.9m
CAGR 3-Years
37%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Net Income (Common)
$6B
CAGR 3-Years
-2%
CAGR 5-Years
15%
CAGR 10-Years
17%
Danaher Corp
NYSE:DHR
Net Income (Common)
$4.7B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
6%
West Pharmaceutical Services Inc
NYSE:WST
Net Income (Common)
$593.4m
CAGR 3-Years
20%
CAGR 5-Years
23%
CAGR 10-Years
18%
Agilent Technologies Inc
NYSE:A
Net Income (Common)
$1.2B
CAGR 3-Years
15%
CAGR 5-Years
2%
CAGR 10-Years
5%
IQVIA Holdings Inc
NYSE:IQV
Net Income (Common)
$1.4B
CAGR 3-Years
69%
CAGR 5-Years
39%
CAGR 10-Years
20%

See Also

What is Chromadex Corp's Net Income (Common)?
Net Income (Common)
-4.9m USD

Based on the financial report for Dec 31, 2023, Chromadex Corp's Net Income (Common) amounts to -4.9m USD.

What is Chromadex Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
32%

Over the last year, the Net Income (Common) growth was 70%. The average annual Net Income (Common) growth rates for Chromadex Corp have been 37% over the past three years , 32% over the past five years .